President and CEO · BAXTER INTERNATIONAL INC (BAX)

Andrew Hider

FY2025 is the first fiscal year CompBrief holds for Andrew Hider as a named executive officer of BAXTER INTERNATIONAL; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2025

$29,805,182

1st of 9 named executive officers at Baxter International by FY2025 total.

9 named officers on file for BAXTER INTERNATIONAL, FY2025

See an example →

What this number hides

The filing gives the total. BAXTER INTERNATIONAL’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Compensation figures as of the proxy filed March 23, 2026 (DEF 14A). Insider transactions since that proxy, current to 2026-11-07.

Free

Get Andrew Hider’s full pay file as a PDF — free

More than this page: up to 10 years of Andrew’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Andrew Hider and every company like it: Velarion Intel, free for 3 days, no card →

Andrew Hider compensation by year

BAXTER INTERNATIONAL Summary Compensation Table · the one fiscal year held
In US dollars, as BAXTER INTERNATIONAL reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$499,315
Bonus$1,000,000
Stock awards$23,133,518
Option awards$3,185,053
Non-equity incentive$820,125
Pension and deferred compensation$0
All other$1,167,171
Total$29,805,182

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BAXTER INTERNATIONAL INC DEF 14A filed March 23, 2026, accession 0001628280-26-020330, and prior-year filings. Open the filing on EDGAR.

How this page was built: the BAXTER INTERNATIONAL INC filed document, accession 0001628280-26-020330. Every figure is read from that document and cited to the page and table it appears in. Filed March 23, 2026.

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU236,237$4,514,489—
RSU131,813$2,518,946—
PSU131,813$2,518,946—
PSU82,170$1,570,259—
PSU56,492$1,079,553—
Option465,651—$24.17

Per the Outstanding Equity Awards at Fiscal Year-End table in BAXTER INTERNATIONAL INC's FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

1 Form 4 line since the FY2025 proxy (filed March 23, 2026)
current to 2026-11-07 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-09-02Tax withholding—54,276$25.70518,447

The 1 most recent of 1 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Change-in-control & termination

estimated payments BAXTER INTERNATIONAL discloses, by trigger · FY2025
TriggerCash severanceAccelerated equityBenefits continuationTotal as disclosed
Change in control and involuntary termination$8,437,500$17,370,952$34,000$27,411,202
Involuntary termination without cause$6,750,000$4,514,489$32,000$12,166,614

Per the Potential Payments Upon Termination or Change in Control table in BAXTER INTERNATIONAL INC's FY2025 proxy. Estimates as the company printed them; a dash means it printed no figure.

BAXTER INTERNATIONAL’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Andrew Hider · this pagePresident and CEO$29,805,182
Joel GradeFormer Executive Vice President and CFO$8,209,568
José AlmeidaFormer Chair of the Board, President and CEO$7,666,044
Heather KnightFormer Executive Vice President, COO and Interim Group President, Medical Products & Therapies$6,074,548
Reazur RasulExecutive Vice President and Group President, Healthcare Systems & Technologies$5,246,214
Alok SonigFormer Executive Vice President and Group President, Pharmaceuticals$5,239,273
Brent ShaferNon-Executive Chair and Former Executive Chair and Interim CEO$3,809,993
David RosenbloomExecutive Vice President and General Counsel$3,794,164
Cecilia SorianoGroup President, Infusion Therapies & Technologies and Pharmaceuticals$2,654,841

The full BAXTER INTERNATIONAL compensation record

free company brief

This page is one person within BAXTER INTERNATIONAL's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the BAXTER INTERNATIONAL proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order BAXTER INTERNATIONAL's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are BAXTER INTERNATIONAL's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Order BAX

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Andrew Hider's compensation dossier